Foundation Medicine Collaborates with Sumitomo Pharma America to Advance Investigational Treatment for Patients with Acute Leukemia with NPM1 Mutations or KMT2A Rearrangements Using the FoundationOne®Heme Platform Yahoo Finance Nawigacja wpisu Geriatric medicine among least popular options for new docs – Axios Hong Kong Hospital Authority to cap medical supply for patients to 24 weeks – South China Morning Post
